Forex Today: Positive sentiment persists even with ongoing uncertainty surrounding US-Iran negotiations
Market Overview for Wednesday, March 25
On Wednesday, optimism prevails in early European trading as investors weigh the likelihood of easing tensions in the Middle East. Key data releases today include Germany’s IFO sentiment survey and the latest US Export and Import Price Index figures, as outlined in the economic calendar.
Tuesday’s US session saw reports from Israeli Channel 12 suggesting a potential year-long ceasefire, based on a plan developed by Steve Wikoff and Jared Kushner. The proposal, which reportedly contains 15 points that must be agreed upon before reopening the Strait of Hormuz, is expected to be negotiated during the ceasefire. Following this news, the US Dollar Index pulled back from its daily highs and finished the session nearly flat.
Meanwhile, early Wednesday, Iran’s Revolutionary Guards announced missile strikes targeting Israel and US military installations in Kuwait, Jordan, and Bahrain. According to Al Jazeera, Iran’s foreign ministry has denied any ongoing negotiations and vowed to continue its military actions.
During the European session, the US Dollar (USD) Index holds modest gains around 99.40. US stock index futures are up between 0.6% and 0.7%. Crude oil prices remain subdued, with West Texas Intermediate (WTI) trading well below the $90 mark.
In the UK, the Office for National Statistics reported that annual inflation, measured by the Consumer Price Index, remained steady at 3% in February, matching forecasts. Core CPI increased by 3.2%, slightly above the expected 3.1%. The Retail Price Index rose by 0.4% month-over-month. As a result, GBP/USD faces mild downward pressure, trading below 1.3400.
Australian data revealed that annual CPI inflation eased to 3.7% in February, down from 3.8% in January. AUD/USD continues to weaken, recently down about 0.5% near 0.6960.
After a late-session recovery on Tuesday, EUR/USD is struggling to regain upward momentum and remains below 1.1600 in Wednesday’s European trading.
Gold continues its upward trend, building on Tuesday’s positive close. The precious metal is trading above $4,500, up more than 1.5% for the day.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.
Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market
Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.
Crypto prices
More
